Early researchers, including Guillaume Benjamin Amand Duchenne, the French neurologist who described DMD in 1861, proposed that super-imposing electrical stimulation on dystrophin-deficient muscles could serve as a potential therapy (Barnard et al., 1986; Duchenne, 1870; Reichmann et al., 1981). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.